Clinical Trial Update: Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azacytidine combined with lenalidomide as maintenance therapy guided by MRD monitoring in acute myeloid leukemia in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia in Remission

Drugs mentioned

• Lenalidomide (lenalidomide)
• azacytidine (azacitidine)

Snippet

Sponsor: Ge Zheng | Conditions: Acute Myeloid Leukemia in Remission | Phase 3 | Status: UNKNOWN